Everfront Biotech Inc.
PrivateLast Round
IPO
Jan 3, 2025
Total Funding Raised
$9.58M
Company Overview
Everfront Biotech Inc. is a biotechnology company that develops orphan drugs for hard-to-treat diseases such as glioblastoma, pancreatic cancer, and amyotrophic lateral sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everfront Biotech Inc. Comparables
Compare Everfront Biotech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeOnc Technologies Holdings, Inc. | 83% | |
| Eisai | 82% | |
| NanOlogy, LLC | 77% | |
Everfront Biotech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 3, 2025 | ||||
| Convertible Debt | Jul 12, 2023 | ||||
| Grant | Sep 1, 2017 | ||||
| Grant | Dec 1, 2014 | ||||
| Grant | May 1, 2013 |
Everfront Biotech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ROTH Capital Partners | IPO |
| Sutter Securities, Inc. | IPO |
| The Benchmark Company | IPO |
| Ministry of Economic Affairs, Taiwan | Grant |
| Boustead Securities | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 3, 2025
$10M raised with ROTH Capital Partners and others.
- Jul 12, 2023
Raised $8M in convertible debt.
Everfront Biotech Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Everfront Biotech Inc.'s valuation, stock price, and market status.